Similar to a heart transplant, the FDA-approved Total Artificial Heart replaces both failing heart ventricles and the four heart valves, eliminating the symptoms and source of end-stage biventricular failure. It is currently approved as a bridge to transplant for people dying from end-stage heart failure affecting both ventricles.
Read the health system news release about UI Healthcare’s artificial heart transplant.
Related Articles on Hospital Key Specialties:
Study: Cooling Therapy Effectively Treats Out-of-Hospital Cardiac Arrest
Trial Begins for Maryland Cardiologist Accused of Implanting 200 Unnecessary Stents
Triple Kidney Exchanges May Increase Kidney Transplants
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
